On May 19, 2025, Evofem Biosciences entered into a License and Supply Agreement with Pharma 1 Drug Store allowing them exclusive rights to develop and sell SOLOSEC in the UAE and other Middle Eastern countries for five years, including milestone payments and regulatory approvals.